Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 866 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Apothecary to distribute Pfizer Inlyta drug

Inlyta (axitinib) was approved by the FDA for the treatment of advanced renal cell carcinoma (RCC) after failure of one systemic therapy. Inlyta, an oral drug, inhibits certain

Teva UK introduces generic Glaucoma drops

The product is indicated in the treatment of the reduction of elevated intraocular pressure in patients with open angle glaucoma and ocular hypertension. Latanoprost + Timolol is currently

Avanir AVP-923 shows safety and efficacy results

AVP-923 combines dextromethorphan hydrobromide and low dose quinidine sulfate, and is currently being investigated in a Phase II clinical trial in central neuropathic pain in patients with multiple